Cited by 229Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsHemophilia Treatment and Research

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Laboratory Identification of Lupus Anticoagulants: Results of the Second International Workshop for Identification of Lupus Anticoagulants: On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH

Brandt, John T, Barna, Linda K, Triplett, Douglas A·1995·Thrombosis and Haemostasis

DOI 10.1055/s-0038-1649988

Open this paper in CoChat — free account

Abstract

Summary: Lupus anticoagulants (LAs) are antibodies that interfere with phospholipid dependent coagulation reactions in vitro. This workshop was designed to provide the participants with an experience in identification of LAs, to evaluate different criteria for mixing studies, to assess the performance of recently introduced confirmatory studies and to assess the performance of two potential surrogate LA control plasmas. The results demonstrate that there continues to be significant variation in the sensitivity and responsiveness of APTT reagents to the presence of LAs, confirming the need for more than one screening assay before the presence of a LA can be ruled out. In this workshop, the best distinction between factor deficiency and inhibitors was obtained using a 1:1 mix of normal plasma with patient plasma and the criterion defining correction as shortening of the APTT to within 5 s of the APTT of pooled normal plasma. A 4:1 mix of patient to normal plasma did not work well in distinguishing factor deficiency from inhibitors. The platelet neutralization procedure, DVVconfirm® and StaClot LA® all gave positive results with the LA samples. False positive platelet neutralization procedures were seen with the samples from patients on oral anticoagulants and a factor V inhibitor. False positive StaClot LA results were obtained with high titer factor VIII inhibitors. Both of the potential surrogate plasmas gave variable results with multiple assays; they can not be recommended for routine use at present.

Integrity signals

Registry

Crossref · 10.1055/s-0038-1649988

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin
Bevers, E. M., Galli, M., Barbui, T., Comfurius, P., & Zwaal, R. F. A. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646476 · Cited by 575
Thrombosis in Patients with the Lupus Anticoagulant
Mueh, J., HERBST, K. D., & RAPAPORT, S. I. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-156 · Cited by 502
Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]
Oosting, J. D., Derksen, R. H. W. M., Bobbink, I. W. G., Hackeng, T. M., Bouma, B. N., & de Groot, P. G. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 487
Immunology and clinical importance of antiphospholipid antibodies
McNeil, H. P., Chesterman, C. N., & Krilis, S. A. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60777-4 · Cited by 481
The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
Thiagarajan, P., Pengo, V., & Shapiro, S. (1986) · Blood · doi:10.1182/blood.v68.4.869.869 · Cited by 422
The Spectrum of Neurologic Disease Associated With Antiphospholipid Antibodies
Levine, S. R. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520200078024 · Cited by 301
INTRAUTERINE DEATH AND CIRCULATING ANTICOAGULANT (“ANTITHROMBOPLASTIN”)
Nilsson, I. M., Åstedt, B., Hedner, U. K. E., et al. (1975) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1975.tb04897.x · Cited by 293
Laboratory Diagnosis of Lupus Inhibitors: A Comparison of the Tissue Thromboplastin Inhibition Procedure with a New Platelet Neutralization Procedure
Triplett, D. A., Brandt, J. T., Kaczor, D. A., et al. (1983) · American Journal of Clinical Pathology · doi:10.1093/ajcp/79.6.678 · Cited by 276
Self-citation
Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants.
Exner, T., Triplett, D. A., Taberner, D. A., & Machin, S. J. (1991) · PubMed · Cited by 243
Self-citation

Show all 27 references

Sorted by citations

Items 101–200 of 229

Acquired immune-mediated thrombophilia in lymphoproliferative disorders
Lechner, K., Simonitsch, I., Haselböck, J., Jaeger, U., & Pabinger, I. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.580474 · Cited by 22
Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents
Sølvik, U. Ø., Petersen, P. H., Monsen, G., Stavelin, A. V., & Sandberg, S. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.146233 · Cited by 22
Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time
Benzon, H. T., Park, M., McCarthy, R. J., et al. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003457 · Cited by 21
True anti‐anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activity
Gallart, T., Benito, C., Reverter, J. C., Bosch, F., Blay, M., Tàssies, D., Vigorito, E., Cervera, R., Font, J., Gomis, R., et al. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2002.03335.x · Cited by 21
Management of Antiphospholipid Antibody Syndrome
Lim, W., & Crowther, M. A. (2008) · Wiley eBooks · doi:10.1002/9781444300857.ch21 · Cited by 21
Clinical consequences of antiphospholipid antibodies.
Derksen, R. H. W. M., & de Groot, P. G. (2004) · PubMed · Cited by 20
Catastrophic antiphospholipid syndrome in a community-acquired methicillin-resistant Staphylococcus aureus infection: A review of pathogenesis with a case for molecular mimicry
Martin, E., Winn, R. E., & NUGENT, K. M. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.09.023 · Cited by 19
Anti‐phosphatidylserine prothrombin antibodies as a predictor of the lupus anticoagulant in an all‐comer population
Pham, M., Orsolini, G., Crowson, C. S., Snyder, M. R., Pruthi, R. K., & Moder, K. G. (2022) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15792 · Cited by 20
Clinical relevance of the recent update of the classification criteria for definite antiphospholipid syndrome: an obstetric medicine clinic series of 107 patients
Pourrât, O., JOLLIT, C., Gombert, J., Boinot, C., & Pierre, F. H. F. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02142.x · Cited by 19
Abnormal optical waveform profiles in coagulation assays from patients with antiphospholipid antibodies
Su, Z., Braun, P. J., Klemp, K. F., Baker, K. R., Thames, E. H., & Ortel, T. L. (2002) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200201000-00002 · Cited by 18
Antiphospholipid Syndrome With Catastrophic Bleeding and Recurrent Ischemic Strokes as Initial Presentation of Systemic Lupus Erythematosus
Rodriguez, V., Reed, A. M., Kuntz, N. L., Anderson, P. M., Smithson, W. A., & Nichols, W. L. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000174565.91343.43 · Cited by 17
Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non‐haemophilic patients
Rampersad, A. G., Boylan, B., Miller, C. H., & Shapiro, A. D. (2018) · Haemophilia · doi:10.1111/hae.13565 · Cited by 18
Role of anticardiolipin antibodies in the pathogenesis of prosthetic valve thrombosis
Aykan, A. Ç., Gökdeniz, T., Kalçık, M., Astarcıoğlu, M. A., Gündüz, S., Karakoyun, S., Gürsoy, M. O., Oğuz, A. E., Ertürk, E., Çakal, B., et al. (2014) · Herz · doi:10.1007/s00059-013-4038-1 · Cited by 17
Are anticardiolipin antibodies really important in thromboangiitis obliterans (Buerger’s disease)?
Olin, J. W. (2002) · Vascular Medicine · doi:10.1191/1358863x02vm457ed · Cited by 16
Circulating microparticles in neuropsychiatric systemic lupus erythematosus
Crookston, K. P., Sibbitt, W. L., Chandler, W. L., et al. (2013) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12026 · Cited by 15
Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test
Kumano, O., Ieko, M., Naito, S., Yoshida, M., Takahashi, N., Suzuki, T., & Aoki, T. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.05.030 · Cited by 15
Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma
Plüß, M., Mitteldorf, C., Szuszies, C. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868133 · Cited by 15
Index of circulating anticoagulant cut‐off value establishment in activated partial thromboplastin time mixing test for lupus anticoagulant diagnosis
Kumano, O., Ieko, M., Naito, S., Yoshida, M., Takahashi, N., & Aoki, T. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12345 · Cited by 14
New formulas for mixing test to discriminate between lupus anticoagulant and acquired hemophilia A
Kumano, O., Ieko, M., Naito, S., Yoshida, M., Takahashi, N., Suzuki, T., & Komiyama, Y. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.05.004 · Cited by 13
Primary Antiphospholipid Antibody Syndrome and Cardiac Involvement in a Child
Clauss, S. B., Manco‐Johnson, M. J., Quivers, E. S., et al. (2003) · Pediatric Cardiology · doi:10.1007/s00246-002-0273-6 · Cited by 13
Assessment of thrombotic risk factors predisposing to thromboembolic complications in prosthetic orthopedic surgery
Szűcs, G., Ajzner, É., Muszbek, L., et al. (2009) · Journal of Orthopaedic Science · doi:10.1007/s00776-009-1368-1 · Cited by 13
The antiphospholipid syndrome
Franchini, M., & Veneri, D. (2005) · Hematology · doi:10.1080/10245330500141309 · Cited by 12
Acquired Functional Coagulation Inhibitors: Review on Epidemiology, Results of a Wet-Workshop on Laboratory Detection, and Implications for Quality of Inhibitor Diagnosis
Dardikh, M., Meijer, P., van der Meer, F., et al. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0032-1321490 · Cited by 12
Antiphospholipid Antibodies: Laboratory and Pathogenetic Aspects
Vlachoyiannopoulos, P. G., Samarkos, M., Sikara, M. P., & Tsiligros, P. (2007) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360601079549 · Cited by 12
Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome
Niznik, S., Rapoport, M. J., Avnery, O. H., Lubetsky, A., Shavit, R., Ellis, M. H., & Agmon‐Levin, N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.824775 · Cited by 11
Role of β2‐glycoprotein I in the pathogenesis of the antiphospholipid syndrome
Li, J., Zhu, X., & Feng, J. (2023) · Rheumatology & autoimmunity · doi:10.1002/rai2.12072 · Cited by 12
Paired APTT s of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT
Kumano, O., Amiral, J., Dunois-Lardé, C., Peyrafitte, M., & Moore, G. W. (2018) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12921 · Cited by 11
Antiphospholipid antibodies in children with systemic lupus erythematosus: a prospective study in northern India
Ahluwalia, J., Singh, S., & Garewal, G. (2004) · Rheumatology International · doi:10.1007/s00296-004-0501-x · Cited by 11
The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
Basiri, Z., Gholyaf, M., Faridnia, M., Nadi, E., & Bairanvand, M. (2013) · PubMed · Cited by 11
Antiphospholipid Antibodies:
Riley, R. S., Friedline, J. A., & Rogers, J. S. (1997) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30203-8 · Cited by 10
Cardiopatía valvular en pacientes con síndrome antifosfolipídico
Muñoz, F. J., Reverter, J. C., Franco, J. F., Garriga, G. E., Tàssies, D., & Morin, M. (2002) · Revista Clínica Española · doi:10.1016/s0014-2565(02)71136-3 · Cited by 11
Single Center Review of Clinicopathological Characterization in 77 Patients with Positive Lupus Anticoagulant Antibodies
Owaidah, T. M., Qurashi, F.-H. M., Nounou, R., Zahrani, H. A., Mussa, A. A., Tbakhi, A., Daama, S. A. A., Elkum, N. B., & Roberts, G. T. (2003) · Hematology · doi:10.1080/10245330310001594216 · Cited by 11
Histological appearance of the intra-osseous vessels of the femoral head in aseptic osteonecrosis of the hip, with or without antiphospholipid antibodies
Laroche, M., Ludot, I., Thiéchart, M., et al. (1997) · Clinical Rheumatology · doi:10.1007/bf02242453 · Cited by 11
Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thromboses in patients with the antiphospholipid syndrome
Айсина, Р. Б., Mukhametova, L. I., Ostryakova, E. V., et al. (2013) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750813010010 · Cited by 10
How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive
Giles, I., & Rahman, A. (2009) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2009.01.009 · Cited by 11
Fatal hemorrhage due to a spontaneous factor V inhibitor with lupus anticoagulant properties
Olson, N. J., Robert, D., Hedayat, A. A., et al. (2016) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000603 · Cited by 10
Heart Valve Surgery in Antiphospholipid Syndrome Patients—Morbidity and Mortality
Eviatar, T., Niznik, S., Elkayam, O., Ben‐Gal, Y., Shavit, R., Raanani, E., Agmon‐Levin, N., & Paran, D. (2023) · Life · doi:10.3390/life13040891 · Cited by 9
Ethnicity and Antiphospholipid Syndrome in Israel
Niznik, S., Rapoport, M. J., Avnery, O. H., Ellis, M. H., Yahia, S. H., & Agmon‐Levin, N. (2021) · Arthritis Care & Research · doi:10.1002/acr.24720 · Cited by 9
Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays
Liestøl, S., & Wislöff, F. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.11.013 · Cited by 9
Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method
Chen, J., Phillips, B., & Chandler, W. L. (2015) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000375 · Cited by 9
Hereditary hemorrhagic telangiectasia, factor V Leiden and antiphospholipid syndrome: a case report
Undas, A., Bazan‐Socha, S., Swadźba, J., et al. (2002) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200201000-00008 · Cited by 9
Assessing thrombosis risk in patients with idiopathic, diabetic, and postsurgical gastroparesis
Lobrano, A., Blanchard, K. P., Rock, W., et al. (2006) · Advances in Therapy · doi:10.1007/bf02850315 · Cited by 8
Coagulation and fibrinolysis
Napolitano, M., Schamaier, A., & Kessler, C. M. (2016) · Nova Science Publishers (Nova Science Publishers, Inc.) · Cited by 11
Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin
Kanouchi, K., Narimatsu, H., OHNUMA, O., Morikane, K., & Fukao, A. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2228-y · Cited by 8
Heart valve disease in primary antiphospholipid syndrome
Niznik, S., Rapoport, M. J., Avnery, O. H., Kidon, M. I., Shavit, R., Ellis, M. H., & Agmon‐Levin, N. (2023) · Lara D. Veeken · doi:10.1093/rheumatology/kead399 · Cited by 7
Acute ST-elevation myocardial infarction in a 15-year-old boy with celiac disease and multifactorial thrombotic risk
Picchi, A., Pasqualini, P., D’Aiello, I., et al. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-01-0021 · Cited by 7
Catastrophic Antiphospholipid Syndrome Presenting as Bilateral Central Retinal Artery Occlusions
Saraf, S. S., Patel, Y. P., Desai, A., et al. (2015) · Case Reports in Ophthalmological Medicine · doi:10.1155/2015/206906 · Cited by 7
Livedo, dementia, thrombocytopenia, and endotheliitis without antiphospholipid antibodies: Seronegative antiphospholipid-like syndrome
Duval, A., Darnige, L., Glowacki, F., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.12.046 · Cited by 7
Laboratory Tests for the Antiphospholipid Syndrome
Pericleous, C., Ripoll, V. M., Giles, I., & Ioannou, Y. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0326-9_17 · Cited by 8
Nonhemophilic Inhibitors of Coagulation
Ewenstein, B. M. (2007) · Elsevier eBooks · doi:10.1016/b978-141602401-9.10006-9 · Cited by 7
The Use of Frozen-Thawed Platelet-Derived Phospholipids as a Confirmatory Test for the Diagnosis of Lupus Anticoagulants. Comparison with Two Commercial Confirmatory System Tests
Cappucci, G., Grandone, E., Giuliani, N., et al. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00006-7 · Cited by 7
Prevalence of thrombophilic mutations in patients with unprovoked thromboembolic disease. A comparative analysis regarding arterial and venous disease.
Μανδαλά, Ε., Lafaras, C., Tsioni, C., et al. (2012) · PubMed · Cited by 6
Investigation of a Thrombotic Tendency
Laffan, M., & Manning, R. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6696-2.00019-9 · Cited by 6
Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?
Andréoli, L., Pregnolato, F., Burlingame, R. W., et al. (2011) · Reumatismo · doi:10.4081/reumatismo.2008.185 · Cited by 5
Audit of laboratory investigation of antiphospholipid syndrome
Myers, B., Dolan, G., & Gould, J. C. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.0115_1cr.x · Cited by 6
Lupus Anticoagulants, Antiphospholipid Antibodies, and Antiphospholipid Syndrome
Nichols, W. L., Kottke‐Marchant, K., Ledford-Kraemer, M., Homburger, H. A., & Cardel, L. K. (2012) · Wiley eBooks · doi:10.1002/9781444398595.ch39 · Cited by 6
Fine specificity of antibodies against phospholipids and beta-2-glycoprotein I in monoclonal gammopathy associated neuropathies
Matà, S., Giudizi, M. G., Totaro, M. G., et al. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.10.016 · Cited by 5
Screening for lupus anticoagulant: improving the performance of the lupus-sensitive PTT-LA
Luginbühl, R., Barizzi, G., Sulzer, I., Lämmle, B., & Alberio, L. (2010) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2010.01262.x · Cited by 4
Acquired hemophilia�A presenting as progressive intra‑abdominal hemorrhage, muscle hemorrhage and hemothorax postpartum: A case report and literature review
Xu, L., Chen, J., Zhou, X., et al. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7031 · Cited by 4
Coagulation and Fibrinolysis
Schmaier, A. H., & Miller, J. L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00039-7 · Cited by 4
Síndrome antifosfolipídico primario: características y evolución de una serie de 17 casos
Romero, J. M. C., Dacal, J. C. B., Salado, J. L. R., et al. (2002) · Anales de Medicina Interna · doi:10.4321/s0212-71992002000500003 · Cited by 4
Diagnostic Approach of Phospholipid-Dependent Antibodies
Amiral, J. (1999) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022494 · Cited by 4
Detecting and Quantifying Functional Inhibitors in Hemostasis
Verbruggen, B., Nováková, I. R. O., & van Heerde, W. L. (2008) · Wiley eBooks · doi:10.1002/9781444303575.ch20 · Cited by 4
Patients with deep venous thrombosis and thrombophilia risk factors have a specific prolongation of the lag time in a chromogenic thrombin generation assay
Haas, F. J. L. M., Kluft, C., Biesma, D. H., et al. (2011) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e328347404d · Cited by 3
Acquired Coagulation Disorders Caused by Inhibitors
Kruse‐Jarres, R., & Leissinger, C. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00006-3 · Cited by 3
Hypercoagulable State
Jaiprakash, M., Kumar, H., Chopra, G., et al. (2006) · Medical Journal Armed Forces India · doi:10.1016/s0377-1237(06)80057-2 · Cited by 3
Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation
Kornfehl, A., Brock, R., Staudinger, T., Schellongowski, P., Nagler, B., Hermann, A., Robak, O., Schwameis, M., Quehenberger, P., & Buchtele, N. (2023) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296231207062 · Cited by 4
Lupus Anticoagulants: Mechanistic and Diagnostic Considerations
Arnout, J., & Vermylen, J. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_24 · Cited by 3
Antiphospholipid syndrome and pregnancy
Gadó, K., & Domján, G. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29425 · Cited by 3
Antiphospholipid Antibody Syndrome-Diagnostic Issues of Lupus Anticoagulants
Tyagi, S., & Ahuja, A. (2016) · Journal of Hematology & Thromboembolic Diseases · doi:10.4172/2329-8790.1000253 · Cited by 3
ANTIPHOSPHOLIPID SYNDROME
Avčin, T., & O’Neil, K. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6581-4.10022-6 · Cited by 3
Indication and outcome of lupus anticoagulant and antiphospholipid antibodies testing in routine clinical practice
Kempers, E. K., Dalm, V. A. S. H., van Rijn, M. J. E., Mulders, A. G. M. G. J., Leebeek, F. W. G., de Maat, M. P. M., & Jansen, A. J. G. (2021) · Rheumatology Advances in Practice · doi:10.1093/rap/rkab093 · Cited by 5
Antiphospholipid Syndrome and Thrombosis
Atsumi, T. (2005) · The Japanese Journal of Phlebology · doi:10.7134/phlebol.16-1-1 · Cited by 3
Investigation of a thrombotic tendency
Laffan, M., & Manning, R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3408-4.00019-9 · Cited by 3
Antiphospholipid Antibodies and Preeclampsia
Dreyfus, M., Hédelin, G., Kutnahorsky, R., et al. (2001) · Obstetrics and Gynecology · doi:10.1097/00006250-200101000-00006 · Cited by 2
Chapter 3 Laboratory Heterogeneity of Antiphospholipid Antibodies
Pierangeli, S. S., & Rand, J. H. (2009) · Technical report · doi:10.1016/s1571-5078(08)00403-0 · Cited by 2
A Modified Mixing Test with a Proposed Cutoff Value to Screen for Clotting Factor Inhibitors
Akkawat, B., & Rojnuckarin, P. (2014) · Journal of Hematology and Transfusion Medicine (วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต) · Cited by 2
The Dilute Russell’s Viper Venom Time
Radhakrishnan, K. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-339-8_26 · Cited by 2
Evaluation of Rosners index vs Brandt correction and Chang’s %, in the interpretation of mixing studies at varying dilutions
Baig, M. A., Iqbal, M. S., & Tabassum, A. (2019) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20195220 · Cited by 2
The role of family anamnesis investigation in antiphospholipid syndrome
Chapayeva, N. N., & Трифонова, М. А. (2009) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2009-2-61-68 · Cited by 2
Prevalence of thrombophilic mutations in patients with unprovoked thromboem- bolic disease. A comparative analysis regarding arterial and venous disease
Lafaras, Tsioni, Speletas, et al. (2012) · Cited by 2
Acquired haemophilia A in a patient who is a Jehovah’s Witness
Brown, C., & Page, A. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-244928 · Cited by 2
Co-existent Acquired Haemophilia and Lupus Anticoagulant. A Thorny Issue
Ames, P. R. J., Montero, D., & Archer, J. (2015) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-015-0572-8 · Cited by 2
C‐reactive protein level as a predictor of transient vs. sustained anticardiolipin antibody positivity
Twito, O., Reshef, T., & Ellis, M. H. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00592.x · Cited by 2
Detecting and Quantifying Acquired Functional Inhibitors in Hemostasis
Verbruggen, B., Dardikh, M., & Gorkom, B. A. P. L. (2013) · Wiley eBooks · doi:10.1002/9781118543467.ch12 · Cited by 2
Labordiagnostik von Lupushemmstoffen
Wagner, O., & Quehenberger, P. (2005) · Hämostaseologie · doi:10.1055/s-0037-1619644 · Cited by 2
Risk Quantification in Antiphospholipid Syndrome
Erkan, D. (2010) · Women s Health · doi:10.2217/whe.10.2 · Cited by 1
Standardization of the detection for lupus anticoagulant
Kumano, O., Naito, S., Yamazaki, S., & Ieko, M. (2024) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.35.404 · Cited by 1
Monitoring plasma heparin concentration in a patient with antiphospholipid syndrome
Inaba, T., Yuki, Y., Nishino, S., Komatsu, S., Ishino, H., Tsuji, H., & Fujita, N. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0508-x · Cited by 1
Atteinte cardiaque au cours du syndrome des antiphospholipides
Géri, G., & Cacoub, P. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2011.02.035 · Cited by 1
Laboratory Criteria of Antiphospholipid Syndrome Need to be Updated or Strictly Followed
Martinuzzo, M. E. (2010) · The Open Autoimmunity Journal · Cited by 1
Review: Laboratory Evaluation of the Antiphospholipid Syndrome
Abo, S. M., & DeBari, V. A. (2007) · Cited by 1
Current practices for lupus anticoagulant testing at a tertiary care hospital and impact on laboratory resources
Aljabry, M. S. (2015) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2015.383 · Cited by 1
Investigation of a thrombotic tendency
Laffan, M., & Manning, R. A. (2006) · Elsevier eBooks · doi:10.1016/b0-44-306660-4/50021-0 · Cited by 1
Antiphospholipid syndrome
Khamashta, M. A., Pierangeli, S. S., & Harris, E. N. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00135-4 · Cited by 1
Polineuropatia periférica em pacientes com lúpus eritematoso sistêmico juvenil
Almeida, R. T., Campos, L. M. A., Aikawa, N. E., et al. (2009) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042009000400004 · Cited by 1
Acquired Coagulation Disorders Caused by Inhibitors
Kruse‐Jarres, R., & Leissinger, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00005-4 · Cited by 1
De novo mutation of the β-globin gene initiation codon (ATG→AAG) in a Northern European
Waye, J. S., Eng, B., Patterson, M., Barr, R. D., & Chui, D. H. K. (1997) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199711)56:3 · Cited by 23
Self-citation
IgM interference in determination of antiphospholipid antibodies and erythrocyte sedimentation rate in persistent polyclonal B‐cell lymphocytosis with binucleated lymphocytes
Lesesve, J., Devignes, J., Sokolowska, J., et al. (2011) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2011.01310.x
Lupus y síndrome antifosfolípido en el embarazo
Medina, Y. F., Martínez, J., Martínez, O., et al. (2005) · Redalyc (Universidad Autónoma del Estado de México)

Authors: Brandt, J. T., Barna, L. K., & Triplett, D. A.
Affiliations: The Ohio State University (US)
Ball Memorial Hospital (US)
Venue: Thrombosis and Haemostasis
Publisher: Georg Thieme Verlag KG
Published: 1995
Volume: 74
Issue: 06
Pages: 1597-1603
ISSN: 0340-6245 (ISSN-L)
2567-689X
DOI: 10.1055/s-0038-1649988
OpenAlex: W2417920681
Cited by: 228
References: 27
Citations by year: 2026: 1 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 2 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 8 · 2013: 12 · 2012: 9
FWCI: 4.05
Type: journal article
Language: en
Open access: closed
Locations: Thrombosis and Haemostasis (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
Keywords: lupus anticoagulant, mixing studies, activated partial thromboplastin time, factor deficiency, anticoagulants, factor VIII inhibitors, factor V inhibitor, oral anticoagulants
MeSH terms: Humans, Laboratories, Partial Thromboplastin Time, Predictive Value of Tests, Prothrombin Time, Reproducibility of Results, Lupus Coagulation Inhibitor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Laboratory Identification of Lupus Anticoagulants: Results of the Second International Workshop for Identification of Lupus Anticoagulants: On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks